| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $2.28B | +12.1% |
| Gross profit | $2.28B | — |
| Operating income | $0.76B | — |
| Net income | $0.59B | +34.6% |
| Gross margin | 100.0% | Net margin 25.7% |
| Revenue Q/Q | +5.3% | — |
| Segment | Revenue | Share |
|---|---|---|
| Net Interest Income | $1.63B | 71.4% |
| Noninterest Income | $0.65B | 28.6% |
| Item | Amount | % of revenue |
|---|---|---|
| Tax & other | $0.17B | 7.4% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
CLX ・ CME ・ CMS ・ KO ・ CTSH ・ COHR ・ COIN ・ CL ・ CMCSA ・ FIX ・ COP ・ ED
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies